Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients
Year: 2014
Type: article
Study design: Observational Study
Abstract: BACKGROUND: Thiopurines (azathioprine and mercaptopurine) remain integral to most medical strategies for maintaining remission in Crohn's disease (CD) and ulcerative colitis (UC). Indefinite use of these drugs is tempered by long-term risks. While clinical relapse is noted frequently following drug withdrawal, there are few published data on predictive factors. AIM: To investigate the success of planned thiopurine withdrawal in patients in sustained clinical remission to identify rates and predictors of relapse. METHODS: This was a multicentre retrospective cohort study from 11 centres across the UK. Patients included had a definitive diagnosis of IBD, continuous thiopurine use ≥3 years and withdrawal when in sustained clinical remission. All patients had a minimum of 12 months follow-up post drug withdrawal. Primary and secondary end points were relapse at 12 and 24 months respectively. RESULTS: 237 patients were included in the study (129 CD; 108 UC). Median duration of thiopurine use prior to withdrawal was 6.0 years (interquartile range 4.4-8.4). At follow-up, moderate/severe relapse was observed in 23% CD and 12% UC patients at 12 months, 39% CD and 26% UC at 24 months. Relapse rate at 12 months was significantly higher in CD than UC (P = 0.035). Elevated CRP at withdrawal was associated with higher relapse rates at 12 months for CD (P = 0.005), while an elevated white cell count was predictive at 12 months for UC (P = 0.007). CONCLUSION: Thiopurine withdrawal in the context of sustained remission is associated with a 1-year moderate-to-severe relapse rate of 23% in Crohn's disease and 12% in ulcerative colitis.
DOI: 10.1111/apt.12980
Authors: N. A. Kennedy, R. Kalla, B. Warner, C. J. Gambles, R. Musy, S. Reynolds, R. Dattani, H. Nayee, R. Felwick, R. Harris, S. Marriott, S. M. Senanayake, C. A. Lamb, H. Al‐Hilou, D. R. Gaya, P. M. Irving, J. Mansfield, M. Parkes, T. Ahmad, J. R. F. Cummings, I. D. Arnott, J. Satsangi, A. J. Lobo, M. Smith, J. O. Lindsay, C. W. Lees
Institutions: Western General Hospital, Royal Sussex County Hospital, Royal Hallamshire Hospital, Barts Health NHS Trust, Southampton General Hospital, University of Exeter, Royal Devon & Exeter NHS Foundation Trust, Royal Devon University Healthcare NHS Foundation Trust, Addenbrooke's Hospital, Newcastle University, Guy's and St Thomas' NHS Foundation Trust, Glasgow Royal Infirmary, Royal Victoria Infirmary
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $1,975
OpenAlex ID: W2139792815
